These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14352)

  • 1. Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
    Meltzer HY; Paul SM; Fang VS
    Psychopharmacology (Berl); 1977 Jan; 51(2):181-3. PubMed ID: 14352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    J Cardiovasc Pharmacol; 1983; 5(1):86-9. PubMed ID: 6186865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
    Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
    Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
    Cotes PM; Crow TJ; Johnstone EC; Bartlett W; Bourne RC
    Psychol Med; 1978 Nov; 8(4):657-65. PubMed ID: 364517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors.
    Murugaiah K; Mann S; Theodorou AE; Jenner P; Marsden CD
    Life Sci; 1982 Jul; 31(2):181-8. PubMed ID: 6889662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
    Matsubara R
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
    Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
    Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.
    Hyttel J; Christensen AV
    J Neural Transm Suppl; 1983; 18():157-64. PubMed ID: 6135740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
    Boullin DJ; Grimes RP; Orr MW
    Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsatile growth hormone and prolactin: effects of (+) butaclamol, a dopamine receptor blocking agent.
    Willoughby JO; Brazeau P; Martin JB
    Endocrinology; 1977 Oct; 101(4):1298-303. PubMed ID: 908278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequelae of 6 months continuous administration of cis(Z)-and trans(E)-flupenthixol in the rat.
    Waddington JL; Gamble SJ; Bourne RC
    Eur J Pharmacol; 1981 Feb; 69(4):511-3. PubMed ID: 7195814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
    Galliani G; Restelli A; Rosina R; Glässer A
    Pharmacol Res Commun; 1984 Feb; 16(2):117-27. PubMed ID: 6150500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
    J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.
    Johnstone EC; Crow TJ; Frith CD; Carney MW; Price JS
    Lancet; 1978 Apr; 1(8069):848-51. PubMed ID: 76797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
    Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY
    J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions.
    Cheung CY; Neill AC; Weiner RI
    Neuroendocrinology; 1981 Jun; 32(6):370-4. PubMed ID: 6165920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Flupenthixol increases slow-wave in rats: effect of dopamine receptor blockade.
    Fornal C; Wojcik WJ; Radulovacki M
    Neuropharmacology; 1982 Apr; 21(4):323-5. PubMed ID: 7201087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.